Jackie S. Fairweather, RN

Articles by Jackie S. Fairweather, RN

Phase I Study of Irinotecan and Concurrent Radiation Therapy for Upper GI Tumors

ByRitsuko Komaki, MD,Nora A. Janjan, MD,Jaffer A. Ajani, MD,Patrick M. Lynch, MD,Jackie S. Fairweather, RN,Isaac Raijman, MD,George R. Blumenshein, MD,Linus Ho, MD, PhD,Peter W. T. Pisters, MD,Barry W. Feig, MD,Garrett L. Walsh, MD,Richard Pazdur, MD

Irinotecan (Camptosar) is an active chemotherapeutic agent for lung, gastric, esophageal, and colorectal cancers and a potent radiosensitizer. This phase I study was designed to assess the maximum tolerated dose of weekly

Latest Updated Articles